利用重组新城疫病毒评估日本脑炎病毒E蛋白和NS1蛋白在小鼠中的免疫原性
本研究构建了分别表达日本脑炎病毒E蛋白和NS1蛋白的重组新城疫病毒(rNDV-Ejev和rNDV-NS1jev),在9日龄SPF鸡胚和细胞培养中鉴定后,经鼻内免疫BALB/c小鼠。rNDV-Ejev和rNDV-NS1jev接种可产生针对NDV和JEV的有效中和抗体滴度,并诱导有效的Th1和Th2介导的免疫反应。研究提示E与NS1联合使用可降低仅基于E的免疫在小鼠中的效力,结果提示rNDV-Ejev是有前景的JEV活病毒载体疫苗。
要点
- 构建了分别表达JEV E蛋白和NS1蛋白的重组新城疫病毒rNDV-Ejev和rNDV-NS1jev。
- 经鼻内免疫BALB/c小鼠后产生针对NDV和JEV的有效中和抗体滴度。
- E与NS1联合使用可降低仅基于E的免疫在小鼠中的效力。
核心结论
- 结果提示rNDV-Ejev是有前景的JEV活病毒载体疫苗。
- 本研究为开发针对JEV的重组疫苗提示了一种替代且经济的策略。
研究设计与样本
- 研究构建了分别表达JEV E蛋白和NS1蛋白的重组新城疫病毒(rNDV-Ejev和rNDV-NS1jev)。
- 回收的rNDV-Ejev和rNDV-NS1jev在9日龄SPF鸡胚和细胞培养中进行鉴定。
- 在BALB/c小鼠中经鼻内免疫rNDV-Ejev和rNDV-NS1jev。
主要发现
- rNDV-Ejev和rNDV-NS1jev接种在BALB/c小鼠经鼻内免疫后显示出针对JEV的有效免疫。
- rNDVs接种产生了针对NDV和JEV的有效中和抗体滴度。
- 接种小鼠的细胞因子谱显示有效的Th1和Th2介导的免疫反应。
- 研究提示E与NS1联合使用可降低仅基于E的免疫在小鼠中的效力。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Japanese encephalitis (JE) is the most important cause of acute encephalitis syndrome (AES). Japanese encephalitis virus (JEV), the prototype member of the JE serocomplex, belongs to the genus Flavivirus. The immunogenic proteins envelope (E) and non-structural protein 1 (NS1) of JEV are widely explored for the development of vaccines and diagnostics against JEV. However, there are underlying concerns such as the risk of reversion of live-attenuated vaccines to high virulence, the incomplete inactivation of pathogens in inactivated vaccines and partial vaccine coverage. Newcastle disease virus (NDV) is an efficient viral vaccine vector to express several human and animal immunogenic proteins. In the present study, we have developed a recombinant NDV (rNDV), individually expressing the E and NS1 proteins of JEV (rNDV-Ejev and rNDV-NS1jev). The recovered rNDV-Ejev and rNDV-NS1jev were characterized in 9-day-old SPF embryonated chicken eggs and in cell culture. The vaccination of rNDV-Ejev and rNDV-NS1jev showed effective immunity against JEV upon intranasal immunization in BALB/c mice. The rNDVs vaccination produced effective neutralization antibody titers against both NDV and JEV. The cytokine profiling of the vaccinated mice showed an effective Th1 and Th2 mediated immune response. The study also provided an insight that E, when used in combination with NS1 could reduce the efficacy of only E based immunization in mice. Our results suggested rNDV-Ejev to be a promising live viral vectored vaccine against JEV. This study implies an alternative and economical strategy for the development of a recombinant vaccine against JEV.
引用
- Nath B, Vandna, Saini HM, et al. Evaluation of Japanese encephalitis virus E and NS1 proteins immunogenicity using a recombinant Newcastle disease virus in mice. Vaccine. 2020. PMID: 31955960. doi:10.1016/j.vaccine.2019.11.088
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。